Serotonin-releasing effects of substituted piperazines in vitro
about
Revisiting the serotonin-aggression relation in humans: a meta-analysisPharmacology of serotonin and female sexual behaviorOn serotonin and migraine: a clinical and pharmacological reviewMethylone and mCPP, two new drugs of abuse?Serotonin Transporters, Serotonin Release, and the Mechanism of Fenfluramine NeurotoxicityEvidence for noncompetitive modulation of substrate-induced serotonin release.p-Methylthioamphetamine and 1-(m-chlorophenyl)piperazine, two non-neurotoxic 5-HT releasers in vivo, differ from neurotoxic amphetamine derivatives in their mode of action at 5-HT nerve endings in vitro.The clinical toxicology of the designer "party pills" benzylpiperazine and trifluoromethylphenylpiperazine.N-substituted piperazines abused by humans mimic the molecular mechanism of 3,4-methylenedioxymethamphetamine (MDMA, or 'Ecstasy').Benzylpiperazine: a drug of abuse?N,N-dimethyl-thioamphetamine and methyl-thioamphetamine, two non-neurotoxic substrates of 5-HT transporters, have scant in vitro efficacy for the induction of transporter-mediated 5-HT release and currents.Effects of 5-HT uptake inhibitors, agonists and antagonists on the burying of harmless objects by mice; a putative test for anxiolytic agents.MDMA-like behavioral effects of N-substituted piperazines in the mouse.Evidence for a role of transporter-mediated currents in the depletion of brain serotonin induced by serotonin transporter substrates.Evaluation of phenylpiperazines as targeting agents for neuroblastoma.Acute effects of the designer drugs benzylpiperazine (BZP) and trifluoromethylphenylpiperazine (TFMPP) using functional magnetic resonance imaging (fMRI) and the Stroop task--a pilot study.Headache induced by serotonergic agonists--a key to the interpretation of migraine pathogenesis?The effects of 5-HT and m-chlorophenylpiperazine (m-CPP) on the efflux of [3H]-5-HT from human perfused platelets.Evidence that 5-HT2 receptor activation decreases noradrenaline release in rat hippocampus in vivo.The antimigraine drugs ergotamine and dihydroergotamine are potent 5-HT1C receptor agonists in piglet choroid plexus.A combined approach using transporter-flux assays and mass spectrometry to examine psychostimulant street drugs of unknown content.Investigations into migraine pathogenesis: time course for effects of m-CPP, BW723C86 or glyceryl trinitrate on appearance of Fos-like immunoreactivity in rat trigeminal nucleus caudalis (TNC).Effects of trifluoromethylphenylpiperazine (TFMPP) on interhemispheric communication.Isolation, identification and excretion profile of the principal urinary metabolite of the recently banned designer drug 1-(3-trifluoromethylphenyl)piperazine (TFMPP) in rats.Ionization constants and partition coefficients of 1-arylpiperazine derivatives.Pharmacogenetics of trazodone in healthy volunteers: association with pharmacokinetics, pharmacodynamics and safety.Structure-activity relationships of MDMA and related compounds: a new class of psychoactive drugs?
P2860
Q24289369-AA6D88C5-6DF7-4290-A557-231545B7D993Q26861672-38EF1A58-F1D2-4D94-B5F7-9A58274FB845Q28263827-F6D689A7-80CB-4F30-85BC-707389A344FDQ28284527-2BF71A21-9421-4F0A-9DA9-D9BC2916F6C8Q29399915-67566381-D7C7-44D1-AE6E-428E3FE1F113Q34135689-FD5F6BF3-0425-4FB5-88B6-41815A7911A5Q34152289-5C9F6469-E9A7-486F-B21F-151F81A4E99BQ34178580-952D1FA0-D691-40EE-BEEC-02C9C36D4157Q34360861-A7BF58AD-527B-40A2-861B-F7471B0BFE1DQ34580800-A1801FB1-B6A7-4947-9725-73BDFB316879Q35852310-1DD3770E-3D43-45AF-BD24-C441CBAEE43AQ35871873-FFC15020-4837-4546-8B42-483C50723545Q36151338-3E8AC5A5-5F82-4BD4-973A-6441CE6A3D24Q37705731-3F4E2D1D-F85F-4748-A27D-CC4E0BE2F7A3Q39999076-F4469812-075A-4465-B504-65B88F9A676AQ41040391-0D46CF83-5FEC-4406-8102-5771279D699AQ41364582-558BB83D-05D3-44C5-A96E-7930BEB2EB12Q41825436-73BAB50A-1A1B-49A1-9C1A-8FE50DE4D797Q41972251-3835C871-BB8E-4106-BDFF-E6B09B286ED0Q42079935-D627065B-BB11-45C7-913D-391B450B1677Q42771936-787CAA67-2EDF-40D6-A0CA-9D77506EC312Q43572323-FF9FEC7A-EFAB-4042-B590-BB42B413E710Q43676016-FD1CC555-0D74-4B4F-9E29-95833AEDB44DQ46402149-761944DA-E833-4645-8BC8-97A558522948Q48468191-AAE0969B-ECFF-4544-92DF-CA903685B194Q50072074-41F15355-572E-40D1-9239-9DB418129E37Q52243743-2CE08D9E-452E-4C92-8436-FF771490E541
P2860
Serotonin-releasing effects of substituted piperazines in vitro
description
1984 nî lūn-bûn
@nan
1984 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1984 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
name
Serotonin-releasing effects of substituted piperazines in vitro
@ast
Serotonin-releasing effects of substituted piperazines in vitro
@en
Serotonin-releasing effects of substituted piperazines in vitro
@nl
type
label
Serotonin-releasing effects of substituted piperazines in vitro
@ast
Serotonin-releasing effects of substituted piperazines in vitro
@en
Serotonin-releasing effects of substituted piperazines in vitro
@nl
prefLabel
Serotonin-releasing effects of substituted piperazines in vitro
@ast
Serotonin-releasing effects of substituted piperazines in vitro
@en
Serotonin-releasing effects of substituted piperazines in vitro
@nl
P1476
Serotonin-releasing effects of substituted piperazines in vitro
@en
P2093
D J Pettibone
P304
P356
10.1016/0006-2952(84)90424-6
P407
P50
P577
1984-05-01T00:00:00Z